Edan Instruments, Inc.

SZSE:300206 Stock Report

Market Cap: CN¥6.8b

Edan Instruments Past Earnings Performance

Past criteria checks 1/6

Edan Instruments's earnings have been declining at an average annual rate of -14.8%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 3.5% per year. Edan Instruments's return on equity is 7.7%, and it has net margins of 8.7%.

Key information

-14.8%

Earnings growth rate

-14.7%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate3.5%
Return on equity7.7%
Net Margin8.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Edan Instruments' (SZSE:300206) Weak Earnings May Only Reveal A Part Of The Whole Picture

Apr 04
Edan Instruments' (SZSE:300206) Weak Earnings May Only Reveal A Part Of The Whole Picture

Recent updates

There's Reason For Concern Over Edan Instruments, Inc.'s (SZSE:300206) Massive 28% Price Jump

Oct 01
There's Reason For Concern Over Edan Instruments, Inc.'s (SZSE:300206) Massive 28% Price Jump

Edan Instruments (SZSE:300206) Has Affirmed Its Dividend Of CN¥0.207

Apr 29
Edan Instruments (SZSE:300206) Has Affirmed Its Dividend Of CN¥0.207

Why Investors Shouldn't Be Surprised By Edan Instruments, Inc.'s (SZSE:300206) 25% Share Price Plunge

Apr 18
Why Investors Shouldn't Be Surprised By Edan Instruments, Inc.'s (SZSE:300206) 25% Share Price Plunge

Edan Instruments' (SZSE:300206) Weak Earnings May Only Reveal A Part Of The Whole Picture

Apr 04
Edan Instruments' (SZSE:300206) Weak Earnings May Only Reveal A Part Of The Whole Picture

Edan Instruments, Inc.'s (SZSE:300206) Shares Bounce 28% But Its Business Still Trails The Market

Mar 04
Edan Instruments, Inc.'s (SZSE:300206) Shares Bounce 28% But Its Business Still Trails The Market

Revenue & Expenses Breakdown

How Edan Instruments makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:300206 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 241,796156561350
30 Jun 241,770139573353
31 Mar 241,742119590353
31 Dec 231,938221590347
30 Sep 232,024280587335
30 Jun 231,975290564323
31 Mar 231,993324525313
01 Jan 231,742233494298
30 Sep 221,614170469283
30 Jun 221,606197445271
31 Mar 221,515156441258
31 Dec 211,636231427252
30 Sep 211,687268428240
30 Jun 211,929365429243
31 Mar 212,470696421231
31 Dec 202,319653406218
30 Sep 202,212655383207
30 Jun 201,871522370191
31 Mar 201,226176358193
31 Dec 191,136132345195
30 Sep 191,084117330194
30 Jun 191,048112327185
31 Mar 191,029104327182
31 Dec 1899393321178
30 Sep 1894165315181
30 Jun 1891258218260
31 Mar 1887744243218
31 Dec 1784344270177
30 Sep 1782483307117
30 Jun 17792534150
31 Mar 17747464030
31 Dec 16698263900
30 Sep 16661993750
30 Jun 166121203530
31 Mar 165891253340
31 Dec 155501033310
30 Sep 15546183160
30 Jun 1553243200
31 Mar 15509-83190
31 Dec 14523133110
30 Sep 14494152980
30 Jun 14486292830
31 Mar 14473332700
31 Dec 13455352570

Quality Earnings: 300206 has high quality earnings.

Growing Profit Margin: 300206's current net profit margins (8.7%) are lower than last year (13.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300206's earnings have declined by 14.8% per year over the past 5 years.

Accelerating Growth: 300206's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 300206 had negative earnings growth (-44.2%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).


Return on Equity

High ROE: 300206's Return on Equity (7.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies